Position in ASND
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$58,144
New position
Shares Held
218
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#265
of 303 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026CALDWELL SUTTER CAPITAL, INC. holds $550,133 across 24 Biotechnology names. ASND ranks #4 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,000 | $148,960 | |
| 2 | INSM |
INSMED Inc
|
727 | $77,512 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
118 | $63,360 | |
| 4 | ASND |
Ascendis Pharma A/S
This page
|
218 | $58,144 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
1,554 | $57,917 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
693 | $39,369 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
432 | $25,112 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
626 | $23,424 |
All Filings in ASND
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,144 | 218 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||